Mallinckrodt Inc

Form 483 issued January 29, 2016 · Hobart, New York

Inspection
Jan 26 – Jan 29, 2016
Investigator
Samina S. Khan
Observations
2
Pages
2
FEI number
1317295

In short: On January 29, 2016, FDA issued a Form 483 with 2 observations to Mallinckrodt Inc in Hobart, New York (FEI 1317295) after an inspection that ran Jan 26 – Jan 29, 2016. The investigator was Samina S. Khan. Most observations concern materials and production; the most-cited regulation is 21 CFR 211.142 (warehousing procedures).

At a glance

Materials and production account for 2 of 2 observations.

Materials1
Production1

Most cited: 21 CFR 211.142(b) (1×) · 211.188(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Drug products are not stored under appropriate conditions of temperature so that their identity, strength, quality…

  2. 02

    Batch production and control records for each batch of drug product produced do not include an…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Mallinckrodt Inc?

FDA listed 2 observations on this Form 483, mostly about materials and production. The most-cited regulation is 21 CFR 211.142 (warehousing procedures). The opening words of each observation are shown on this page.

Who inspected Mallinckrodt Inc?

Samina S. Khan is named on this Form 483, for the inspection of Jan 26 – Jan 29, 2016. Each investigator has a profile showing what they cite most.

When was Mallinckrodt Inc inspected by FDA?

The inspection ran Jan 26 – Jan 29, 2016, and the Form 483 is dated January 29, 2016.

How do I get the full Form 483 for Mallinckrodt Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free